Herbas VPB

Print
EN | LT
LT - ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER
EN - ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/357
A61K 31/519
A61K 31/555
A01N 43/58
A61K 45/06
A61P 35/00
European patent
(11) Number of the document 3148336
(13) Kind of document T
(96) European patent application number 15799685.1
Date of filing the European patent application 2015-05-28
(97) Date of publication of the European application 2017-04-05
(45) Date of publication and mention of the grant of the patent 2019-10-02
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/032990
Date 2015-05-28
PCT application publication
(87) Number WO 2015/184145
Date 2015-12-03
Priority applications
(30) Number Date Country code
201462003798 P 2014-05-28 US
201462088200 P 2014-12-05 US
Inventors
(72)
COX, David, US
KREMER, Alton, US
MCGONIGLE, Sharon, US
WU, Jiayi, US
Grantee
(73) Eisai R&D Management Co., Ltd., 6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, JP
Title
(54) ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER
  ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Last update date 2021-04-30